Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02777879 · ClinicalTrials.gov registry record
Lung Microbiome and Inflammation in Early COPD
A clinical trial of Chronic Obstuctive Pulmonary Disease, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 230
- Enrollment target
- 1
- Study location
NCT02777879 is a study of Chronic Obstuctive Pulmonary Disease that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 230 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02777879, a study of Chronic Obstuctive Pulmonary Disease, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 230 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a cross sectional case controlled study to assess lung microbiome and inflammation in smokers with and without Chronic Obstructive Pulmonary Disease (COPD). Investigators will look at active bacterial metabolic pathways in the lower airways using metagenomic and metabolomic approaches an assess relationships among microbiome, metagenome, metabolome and host immune responses in COPD and controls. Investigators believe COPD cases will have higher prevalence of pneumotype supraglottic predominant taxa (SPT) than matched controls.
Conditions Studied
Interventions
- PROCEDURE Bronchoscopy
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2014-05 |
| Est. Completion | 2030-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02777879
The ClinicalTrials.gov registry entry for NCT02777879 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Obstuctive Pulmonary Disease appearing as the primary indexed condition, and to 1 intervention - of which Bronchoscopy is the first listed.
NCT02777879 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02777879 about?
NCT02777879 is a clinical study titled "Lung Microbiome and Inflammation in Early COPD". This is a cross sectional case controlled study to assess lung microbiome and inflammation in smokers with and without Chronic Obstructive Pulmonary Disease (COPD). Investigators will look at active bacterial metabolic pathways in the lower airways using metagenomic and metabolomic approaches an ass...
What is the current status of trial NCT02777879?
This trial is currently recruiting. The enrollment target is 230 participants. The study started on 2014-05. Estimated completion is 2030-08.
What conditions does trial NCT02777879 study?
This clinical trial studies the following conditions: Chronic Obstuctive Pulmonary Disease.
What interventions are being tested in trial NCT02777879?
The interventions under investigation include: Bronchoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT02777879?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02777879 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.